Literature DB >> 4664431

Studies of antibody formation in vitro and in lethally irradiated reconstituted mice. Evidence for an inhibitory function of thymus-derived cells.

D Eidinger, H Pross.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4664431     DOI: 10.1111/j.1365-3083.1972.tb01811.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


× No keyword cloud information.
  7 in total

1.  Regulatory substances produced by lymphocytes : I. Inhibitor of DNA synthesis in the rat.

Authors:  Y Namba; B H Waksman
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

2.  Further studies of thymus-bone marrow cell synergism in cutaneous manifestations of delayed hypersensitivity to methylated human serum albumin. The effect of cortisone acetate.

Authors:  A Ackerman; D Eidinger
Journal:  Immunology       Date:  1973-05       Impact factor: 7.397

3.  In vitro studies of 'antigenic competition'. II. Reconstitution of the immune defect and the relationship between antigen-induced suppression and non-specific enhancement.

Authors:  H Pross; D Eidinger
Journal:  Immunology       Date:  1973-08       Impact factor: 7.397

4.  Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation.

Authors:  D Eidinger; T J Garrett
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

5.  Inhibition of antibody formation during continual stimulation with a strong immunogen.

Authors:  J Gras; M Roca; R Ayats; R Castro; F Duran
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

6.  Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes.

Authors:  R R Rich; C W Pierce
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

7.  Biological expressions of lymphocyte activation : I. Effects of phytomitogens on antibody synthesis in vitro.

Authors:  R R Rich; C W Pierce
Journal:  J Exp Med       Date:  1973-01-31       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.